Labeled CD8+ T cells were stimulated with CD3/CD28 antibodies for 3 days in the presence of tumor‐infiltrating CD11b+ myeloid cells from the control vehicle or TP‐16 treated CT26 tumor‐bearing mice. This evidence concerns the gene CD28 and neoplasm.